News
- Home
- News
admin0 Comments
Sanofi Press Release: Sanofi’s AMETHIST trial for GM2 gangliosidosis discontinued
Today it was announced by Sanofi that the AMETHIST phase 3 study of venglustat for the treatment
Read more
DanielLewi0 Comments
“Spot the Stop” for Tay-Sachs and Sandhoff campaign results
The Campaign: A Resounding Success In the world of advocacy and awareness campaigns, success is
Read more
DanielLewi0 Comments
Azafaros RAINBOW study update: Completion of 12 week phase 2
Azafaros has just announced the successful completion of its 12-week Phase 2 clinical study, RAINBOW,
Read more
DanielLewi0 Comments
New podcast episode: Rare Revelations – Rare Disease Day Edition featuring Patricia Durao
In the latest episode of the CATS Foundation Rare Revelations podcast, listeners were treated to
Read more
DanielLewi0 Comments
Rare Disease Day 2024!
Today, as we come together to shine a light on rare diseases through Rare Disease
Read more
DanielLewi0 Comments
The CATS Foundation at the Externally-Led, Patient-Focused Drug Development (EL-PFDD) Meeting for GM2
Last week, the Cure & Action for Tay-Sachs (CATS) Foundation had the incredible opportunity to participate in
Read more
DanielLewi0 Comments
The CATS Foundation at WORLDSymposium 2024 – a review of a great week of science and research
We're thrilled to share the highlights from our experience at the recent WORLDSymposium, where we
Read more
DanielLewi0 Comments
Poster presented at the WORLDSymposium 2024 about our Clinical Toolkit project
We were excited to share some of our work at the recent WORLDSymposium event in
Read more
PatriciaDurao0 Comments
New publication in the National Health Executive about our Clinical Toolkit for Tay-Sachs and Sandhoff disease
In a groundbreaking move towards enhancing support for patients and families affected by rare diseases,
Read more